481 related articles for article (PubMed ID: 18718178)
1. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
Huang ZR; Hua SC; Yang YL; Fang JY
Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
3. Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells.
Fang JY; Hung CF; Hua SC; Hwang TL
Ultrasonics; 2009 Jan; 49(1):39-46. PubMed ID: 18554679
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles for parenteral drug delivery.
Wissing SA; Kayser O; Müller RH
Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
Lee MK; Lim SJ; Kim CK
Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
7. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
8. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
Saupe A; Gordon KC; Rades T
Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
10. Skin moisturizing effect and skin penetration of ascorbyl palmitate entrapped in solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) incorporated into hydrogel.
Uner M; Wissing SA; Yener G; Müller RH
Pharmazie; 2005 Oct; 60(10):751-5. PubMed ID: 16259122
[TBL] [Abstract][Full Text] [Related]
11. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
12. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
Souto EB; Wissing SA; Barbosa CM; Müller RH
Int J Pharm; 2004 Jun; 278(1):71-7. PubMed ID: 15158950
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanoparticles for parenteral delivery of actives.
Joshi MD; Müller RH
Eur J Pharm Biopharm; 2009 Feb; 71(2):161-72. PubMed ID: 18824097
[TBL] [Abstract][Full Text] [Related]
14. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier.
Schubert MA; Müller-Goymann CC
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):77-86. PubMed ID: 16011893
[TBL] [Abstract][Full Text] [Related]
16. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo].
Hu LD; Tang X; Cui FD
Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations.
Souto EB; Wissing SA; Barbosa CM; Müller RH
Eur J Pharm Biopharm; 2004 Jul; 58(1):83-90. PubMed ID: 15207541
[TBL] [Abstract][Full Text] [Related]
18. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window].
Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
20. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].
He J; Hou SX; Feng JF; Cai BQ
Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(21):1651-3. PubMed ID: 16400939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
